Penumbra Inc. (PEN)

$333.50

up-down-arrow $6.50 (1.99%)

As on 22-Apr-2026 10:45EDT

Market cap

info icon

$12,941 Mln

Revenue (TTM)

info icon

$1,404 Mln

P/E Ratio

info icon

73

P/B Ratio

info icon

9.1

Div. Yield

info icon

0 %

Penumbra (PEN) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 329.85 High: 334.00

52 Week Range

Low: 221.26 High: 362.41

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $130 Mln

  • ROEROE information

    0.1 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    56.3

  • Debt to EquityDebt to Equity information

    0.2

  • Book ValueBook Value information

    $36.2

  • EPSEPS information

    $4.5

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    39,243,053

10 Years Aggregate

CFO

$44.61 Mln

EBITDA

$247.81 Mln

Net Profit

$151.46 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Penumbra (PEN)
7.3 -0.7 -6.8 23.2 6.0 3.3 19.9
BSE Sensex
-7.3 5.3 -4.1 -1.1 9.6 10.5 11.7
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 22-Apr-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
Penumbra (PEN)
30.9 -5.5 13.1 -22.6 64.2 6.5 34.4
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Penumbra (PEN)
333.5 12,941.2 1,403.7 177.7 14.7 13.8 73 9.1
8.4 5,633.8 6,552.2 -530.2 -4.1 -9.2 -- 1.0
277.0 7,476.3 2,583.2 759.9 25.2 10.8 9.9 1.0
39.6 6,195.5 3,436.5 -8.6 2.2 -0.4 -- 2.4
27.5 4,414.8 2,719.5 47.0 8.4 1.6 96.2 1.4
122.9 6,939.8 507.4 -187.7 -36.2 -26.4 -- 10.6
82.1 5,456.9 1,541.6 233.6 21.6 21.4 24.6 5.0
178.4 9,341.0 1,526.9 -151.5 20.0 -17.1 46.6 12.9
130.6 7,400.2 738.3 48.9 11.4 2.4 150.8 3.5
32.7 14,139.4 6,178.4 626.5 13.0 11.9 23.2 2.6

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Penumbra (PEN)

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the...  Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California. Address: One Penumbra Place, Alameda, CA, United States, 94502  Read more

  • Co-Founder, Chairman, President & CEO

    Mr. Adam Elsesser

  • Co-Founder & Director

    Dr. Arani Bose M.D.

  • Headquarters

    Alameda, CA

  • Website

    https://www.penumbrainc.com

Edit peer-selector-edit
loading...
loading...

FAQs for Penumbra (PEN)

The share price of Penumbra Inc (PEN) is $333.50 (NYSE) as of 22-Apr-2026 10:45 EDT. Penumbra Inc (PEN) has given a return of 6.01% in the last 3 years.

The P/E ratio of Penumbra Inc (PEN) is 72.96 times as on 13-Apr-2026.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
68.93
8.58
2024
665.53
8.10
2023
108.66
8.38
2022
-4,322.18
8.66
2021
4,102.34
11.28

The 52-week high and low of Penumbra Inc (PEN) are Rs 362.41 and Rs 221.26 as of 22-Apr-2026.

Penumbra Inc (PEN) has a market capitalisation of $ 12,941 Mln as on 13-Apr-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Penumbra Inc (PEN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.